Health Ministry to Restrict Treatments, Control Medications

Public Health Ministry Adapts to Global Supply Chain Disruptions

Bangkok, Thailand – The Ministry of Public Health is implementing a multi-pronged strategy to address escalating resource pressures, exacerbated by global medical supply chain vulnerabilities stemming from ongoing Middle East conflicts. The plan involves strategic limitations on certain medical treatments, an expansion of telemedicine services, and enhanced pharmaceutical management to ensure continued patient care amidst potential shortages and rising costs.

Dr. Somruek Chungsaman, Permanent Secretary for Public Health, outlined the ministry’s proactive measures. The current geopolitical climate is projected to significantly increase the cost of drugs and medical supplies. In response, the ministry is revising treatment protocols and intensifying the oversight of pharmaceutical stock levels.

Fiscal Prudence and Prioritizing Care

Discussions have already taken place with the National Health Security Office (NHSO). The ministry has formally requested that no new benefits be introduced under the existing 30-baht universal healthcare scheme during this period of heightened pressure. This measure aims to conserve financial resources and focus on essential services.

Furthermore, Dr. Somruek has urged the NHSO to consider reallocating funds from the disease prevention and health promotion budget towards more critical programmes. He highlighted persistent health concerns such as anaemia in pregnant women, which remains at approximately 20%, and the ongoing issue of low birth weight infants.

“The budget must be allocated with greater discernment, prioritizing activities that yield tangible and impactful outcomes,” Dr. Somruek stated. “Our focus will be on essential treatments. We will also be limiting inpatient bed utilization for chronic disease patients whose conditions do not necessitate hospitalisation, as a means to effectively manage costs.”

Hospitals are currently experiencing strain due to patients who could be managed effectively outside of inpatient settings. To alleviate this pressure, surgical procedures will be prioritized for urgent cases. This includes critical interventions such as knee replacements, stent placements, and cataract operations.

Leveraging Technology for Enhanced Access

A key component of the ministry’s strategy is the significant expansion of telemedicine services within state hospitals. The aim is to increase the coverage of outpatient care provided through remote consultations from the current modest 2-3% to approximately 30%. This initiative is designed to improve accessibility and reduce the burden on physical hospital facilities.

Stable chronic patients will be strongly encouraged to transition to remote consultations. This shift will be supported by shorter prescription refill periods and, where feasible, the implementation of home delivery services for medications. This approach not only enhances convenience for patients but also frees up hospital resources.

Securing Supply Chains and Pharmaceutical Oversight

In parallel with expanding service delivery, the ministry is actively engaged in safeguarding the nation’s medical supply chain. Collaborations are underway with the Government Pharmaceutical Organisation and the Food and Drug Administration to conduct a thorough review of existing stockpiles. Efforts are also focused on identifying and securing alternative suppliers to mitigate risks associated with current geopolitical instabilities.

Thailand currently maintains reserves of essential drugs sufficient for approximately three to four months. However, the ministry acknowledges that certain critical items remain vulnerable should the ongoing conflict escalate.

One such item identified is Warfarin, an anticoagulant medication that is imported from Israel. To address this vulnerability, the ministry is actively arranging for alternative sources of Warfarin from India, China, and Europe. Beyond this specific drug, authorities are also scrutinizing supplies for essential medical materials, including those used for peritoneal dialysis.

To further strengthen pharmaceutical management, healthcare professionals will be encouraged to prioritize the prescription of medicines listed on the national essential drugs list. A national dashboard is also in development. This centralized monitoring system will provide real-time insights into inventory levels, help prevent hoarding of medical supplies, and facilitate the negotiation of robust long-term procurement contracts. These measures are crucial for ensuring a resilient and responsive healthcare system.